Pulmonary, Allergy, and Critical Care Division, Airway Biology Initiative, Department of Medicine, Cardiovascular Institute, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Am J Physiol Lung Cell Mol Physiol. 2010 Jul;299(1):L25-35. doi: 10.1152/ajplung.00228.2009. Epub 2010 Apr 9.
Severe asthma is characterized by increased airway smooth muscle (ASM) mass due, in part, to ASM cell growth and contractile protein expression associated with increased protein synthesis. Little is known regarding the combined effects of mitogens and interferons on ASM cytosolic protein synthesis. We demonstrate that human ASM mitogens including PDGF, EGF, and thrombin stimulate protein synthesis. Surprisingly, pleiotropic cytokines IFN-beta and IFN-gamma, which inhibit ASM proliferation, also increased cytosolic protein content in ASM cells. Thus IFN-beta alone significantly increased protein synthesis by 1.62 +/- 0.09-fold that was further enhanced by EGF to 2.52 +/- 0.17-fold. IFN-gamma alone also stimulated protein synthesis by 1.91 +/- 0.15-fold; treatment of cells with PDGF, EGF, and thrombin in the presence of IFN-gamma stimulated protein synthesis by 2.24 +/- 0.3-, 1.25 +/- 0.17-, and 2.67 +/- 0.34-fold, respectively, compared with growth factors alone. The mammalian target of rapamycin (mTOR)/S6 kinase 1 (S6K1) inhibition with rapamycin inhibited IFN- and EGF-induced protein synthesis, suggesting that IFN-induced protein synthesis is modulated by mTOR/S6K1 activation. Furthermore, overexpression of tumor suppressor protein tuberous sclerosis complex 2 (TSC2), which is an upstream negative regulator of mTOR/S6K1 signaling, also inhibited mitogen-induced protein synthesis in ASM cells. IFN-beta and IFN-gamma stimulated miR143/145 microRNA expression and increased SM alpha-actin accumulation but had little effect on ASM cell size. In contrast, EGF increased ASM cell size but had little effect on miR143/145 expression. Our data demonstrate that both IFNs and mitogens stimulate protein synthesis but have differential effects on cell size and contractile protein expression and suggest that combined effects of IFNs and mitogens may contribute to ASM cell growth, contractile protein expression, and ASM remodeling in asthma.
重度哮喘的特征是气道平滑肌 (ASM) 质量增加,部分原因是 ASM 细胞生长和收缩蛋白表达增加,与蛋白质合成增加有关。关于有丝分裂原和干扰素对 ASM 细胞溶质蛋白合成的综合影响知之甚少。我们证明,包括 PDGF、EGF 和凝血酶在内的人类 ASM 有丝分裂原可刺激蛋白质合成。令人惊讶的是,抑制 ASM 增殖的多效细胞因子 IFN-β 和 IFN-γ 也增加了 ASM 细胞的细胞质蛋白含量。因此,IFN-β 单独就可使蛋白质合成增加 1.62 +/- 0.09 倍,而与 EGF 联合使用则可进一步增加到 2.52 +/- 0.17 倍。IFN-γ 单独也可刺激蛋白质合成增加 1.91 +/- 0.15 倍;在存在 IFN-γ 的情况下,用 PDGF、EGF 和凝血酶处理细胞可分别使蛋白质合成增加 2.24 +/- 0.3-、1.25 +/- 0.17-和 2.67 +/- 0.34 倍,而单独使用生长因子时则没有这种效果。用雷帕霉素抑制哺乳动物靶蛋白 rapamycin (mTOR)/S6 激酶 1 (S6K1) 的活性可抑制 IFN 和 EGF 诱导的蛋白质合成,这表明 IFN 诱导的蛋白质合成受到 mTOR/S6K1 激活的调节。此外,过度表达作为 mTOR/S6K1 信号的上游负调控因子的肿瘤抑制蛋白结节性硬化复合物 2 (TSC2) 也可抑制 ASM 细胞中的有丝分裂原诱导的蛋白质合成。IFN-β 和 IFN-γ 刺激 miR143/145 微 RNA 的表达并增加 SM α-肌动蛋白的积累,但对 ASM 细胞大小几乎没有影响。相比之下,EGF 增加 ASM 细胞大小,但对 miR143/145 的表达几乎没有影响。我们的数据表明,IFN 和有丝分裂原均可刺激蛋白质合成,但对细胞大小和收缩蛋白表达有不同的影响,这表明 IFNs 和有丝分裂原的综合作用可能导致哮喘中 ASM 细胞生长、收缩蛋白表达和 ASM 重塑。